A larger clinical trial randomly assigned more than 500 patients with type 2 diabetes and symptomatic peripheral neuropathy to one of the following treatments: (i) 600 mg/day of intravenous lipoic acid for three weeks followed by 1,800 mg/day of oral lipoic acid for six months, (ii) 600 mg/day of intravenous lipoic acid for three weeks followed by oral placebo for six months, or (iii) intravenous placebo for three weeks followed by oral placebo for six months (76)
Mol Cell 76(5):838851.e5 Chen P, Li X, Zhang R, Liu S et al (2020) Combinative treatment of -elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation
PubMed Central , Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology , vol
The liposomal shell is biocompatible and helps restore the compromised skin barrier, making these formulations excellent for "SOS" recovery balms and post-care lotions
xa tm tay tr em
These nutrients could help immediately and for days to come